0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Resistance to Ibritumomab in Lymphoma (Hardcover, 1st ed. 2018) Loot Price: R3,234
Discovery Miles 32 340
You Save: R440 (12%)
Resistance to Ibritumomab in Lymphoma (Hardcover, 1st ed. 2018): Makoto Hosono, Jean-Francois Chatal

Resistance to Ibritumomab in Lymphoma (Hardcover, 1st ed. 2018)

Makoto Hosono, Jean-Francois Chatal

Series: Resistance to Targeted Anti-Cancer Therapeutics, 18

 (sign in to rate)
List price R3,674 Loot Price R3,234 Discovery Miles 32 340 | Repayment Terms: R303 pm x 12* You Save R440 (12%)

Bookmark and Share

Expected to ship within 12 - 17 working days

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

General

Imprint: Springer International Publishing AG
Country of origin: Switzerland
Series: Resistance to Targeted Anti-Cancer Therapeutics, 18
Release date: May 2018
First published: 2018
Editors: Makoto Hosono • Jean-Francois Chatal
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 158
Edition: 1st ed. 2018
ISBN-13: 978-3-319-78237-9
Categories: Books > Medicine > Clinical & internal medicine > Endocrinology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-319-78237-1
Barcode: 9783319782379

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners